1st Quarter Financial Results for FYE 3/2007 (Consolidated)
Name of listed company: TERUMO CORPORATION( URL http://www.terumo.com/ )Company code number: 4543
Representative:
Akira Takahashi, President
Please address all communications to:
Kunio Kimishima, General Manager, Corporate Communication Dept.

July 24, 2006

Exchange where listed: TSE
Location of headquarters (prefecture):
Tokyo

Phone: +81 / 3-3374 - 8111

1. Consolidated Financial Highlights for the three months ended June 2006 - Unaudited(From April 1, 2006 to June 30, 2006)(1) Consolidated financial results(Note: The amounts shown below ignore values of less than a million yen)
Net sales

Operating income(Millions of yen)Three months ended June, 2006
Three months ended June, 2005
Year ended March, 2006

% (Millions of yen)

64,31958,721
247,048

9.5
7.3

Net income per share

13,46012,044
48,251

Ordinary income% (Millions of yen)

11.8
24.2

Net income% (Millions of yen)

13,453
12,334
48,934

9.1
26.8

%

8,045
7,673
32,4574.8
31.6

Net income per share,
fully diluted(Yen)(Yen)

Three months ended June, 2006
39.63
Three months ended June, 2005
38.69
Year ended March, 2006
160.45* The percentages shown next to net sales, operating income, ordinary income and net income represent year-on-year changes.
(2) Consolidated financial position
Total assets
June 30, 2006
June 30, 2005
March 31, 2006

(Millions of yen)

(Millions of yen)

346,905
308,255
354,648

275,147
224,755
273,309(3) Consolidated statements of cash flows
Cash flows fromoperating activities
Three months ended June, 2006
Three months ended June, 2005
Year ended March, 2006

Stockholders’ equity

Cash flows frominvesting activities

Equity ratio

Book value per share%

(Yen)

79.3
72.9
77.1
Cash flows fromfinancing activities

1,355.24
1,133.30
1,345.52
Cash and cash equivalents,end of the period(Millions of yen)

(Millions of yen)

(Millions of yen)

(Millions of yen)

5,761
4,835
43,380(3,500)(4,016)(54,391)(3,612)(4,265)370

46,62054,19947,963(4) Changes in scope of consolidation and in application of the equity method
Consolidation (new) :2(elimination): None
Equity method (new) :None(elimination): None
(5) All financial results for the consolidated financial period from April 1, 2006 to June 30, 2006 are not audited
by independent auditors.

2. Consolidated forecasts for the year ending March 2007 (From April 1, 2006 to March 31, 2007)
Net sales(Millions of yen)

Operating income(Millions of yen)

Ordinary income(Millions of yen)

Net income(Millions of yen)Half year ended September, 2006
127,800
26,50026,50016,300Year ended March, 2007
267,000
54,70054,20033,700(N.B.) Estimated net income per share (full year): 165.99 yen(Computing basis: the balance of shares as of the end of this 1st quarter after deduction of Treasury stock)
These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual
results, performance or achievements to differ materially from that anticipated in these statements.

2. Consolidated Financial Statements(1) Consolidated Balance Sheet

I.Current Assets
Cash on cash equivalents
Trade receivable notes/accounts
Inventories
Other current assets
II.Fixed Assets
1. Tangible fixed assets
Building and structures
Machinery and transportation equipment
LandConstruction in progress
Other tangible assets
2. Intangible fixed assets
3. Investments and other assets
Investment in securities
Other investments and other assets
Total Assets

June 30, 2005
Amount%156,81350.9
54,19957,892
36,161
8,559
151,44249.1
107,947
35.0
41,652
28,736
21,6978,811
7,048
22,848
7.4
20,647
6.7
10,123
10,523308,255
100.0

Current Liabilities
Trade payable notes/accounts
Short-term bank loans
Other current liabilities
Long-term Liabilities
Reserve for retirement allowance
Other long-term liabilities
Total Liabilities
Minority Interests
Common stockCapital surplus
Retained earnings
Treasury stock
Total Stockholders' Equity
Other Securities Valuation Difference
Translation Adjustments
Total Valuation and Translation Adjustments
Minority Interests
Total Net Assets

61,761
21,444
11,911
28,405
21,69919,283
2,415
83,461
38-

Total Liabilities and Net Assets-20.0

June 30, 2006
Amount%160,535
46.3
46,62060,37042,545
10,998186,370
53.7
110,23631.8
42,867
29,174
20,257
10,675
7,261
41,12011.8
35,013
10.1
28,8786,135
346,905
100.0

27.1
0.0
-

56,721
22,5383,181
31,002
15,035
11,844
3,191
71,75738,71659,030188,462(13,455)
272,7545,436(3,089)2,347
46275,147-

346,905

7.1

16.4(Millions of yen)March 31, 2006
Amount%165,486
46.7
47,96363,02440,941
13,556
189,16153.3
109,837
31.0
42,591
28,401
20,384
10,697
7,762
41,972
11.8
37,351
10.5
32,162
5,188
354,648
100.0

20.7
11.2
17.0
54.3
(3.9)
78.6
1.6
(0.9)
0.7
0.0
79.3

66,87623,8583,975
39,043
14,412
12,171
2,240
81,28849-

22.9
0.0-100.0-

-

4.3

18.9

4.0

Common stock
Capital surplus
Retained earnings
Other Securities Valuation Difference
Translation Adjustments
Treasury stock
Total Stockholders' Equity

38,71652,103
160,638
1,948(7,155)(21,496)
224,755

12.6
16.9
52.1
0.6
(2.3)
(7.0)
72.9

-

-

38,71659,030183,391
7,367(1,747)(13,449)
273,309

10.9
16.6
51.7
2.1
(0.4)
(3.8)
77.1

Total Liabilities, Minority Interests and Stockholders' Equity

308,255

100.0--354,648

100.0(2) Consolidated Statement of Income

Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Operating income
Non-operating income / expenses
Ordinary income
Extraordinary income / expenses
Income before taxes
Corporate, inhabitant and enterprise taxes
Net income for the period

Three months ended Three months ended
June 30, 2005
June 30, 2006
Amount%Amount%58,721100.0
64,319100.0
26,86145.7
28,44744.3
31,86054.3
35,872
55.7
19,81633.7
22,412
34.8
12,044
20.6
13,46020.9
290(6)12,33421.0
13,453
20.9
(3)
(678)
12,331
21.0
12,775
19.9
4,658
4,729
7,673
13.1
8,045
12.5

(Millions of yen)
Year ended
March 31, 2006
Amount%247,048100.0
111,37745.1
135,67054.9
87,41935.4
48,251
19.5
683
48,93419.8
2,653
51,58820.9
19,13132,457
13.1

Three months ended
June 30, 2005
4,835
(4,016)(4,265)88(3,358)
57,55754,199Three months ended
June 30, 2006
5,761
(3,500)(3,612)8(1,343)
47,963
46,620(Millions of yen)
Year ended
March 31, 2006
43,380(54,391)370
1,046(9,594)
57,55747,963June 30, 2005
175,741

June 30, 2006
187,922(Millions of yen)March 31, 2006
186,091

Three months ended
June 30, 2005
3,470

Three months ended
June 30, 2006
3,826

(Millions of yen)
Year ended
March 31, 2006
18,024Three months ended
June 30, 2005
4637-

Three months ended
June 30, 2006
2243-

(Millions of yen)
Year ended
March 31, 2006
71
4,966
25
156

2759
-

412728(3) Consolidated Statement of Cash Flows

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Effect of exchange rate changes on cash and cash equivalents
Change in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of period(4)Notes
Relating to balance sheet

Accumulated depreciation of tangible assets

Relating to statement of income
Main items among selling, general and administrative expenses

R&D expenditure
Main items among extraordinary income / expenses

Gain on sales of property, plant and equipment
Gain on contribution of securities to retirement benefit trust
Gain on reversal of allowance for bad debts
Gain on sales of trade receivables written off
Loss on disposal of property, plant and equipment
Loss on sales and impairment of golf memberships
Loss on restructuring in subsidiaries
Loss on restructuring in overseas operation
Compensation for retired directors
Expense for acquisition of newly consolidated subsidiary
Impairment loss on property, plant and equipment
Provision for retirement benefits for directors and corporate auditors

6616196575
59473592-3. Segment Information(1) Sales results by product segment
Three months ended Three months ended
June 30, 2005
June 30, 2006
Amount%Amount%Disposable medical equipment
Pharmaceuticals
Blood transfusion systems
General hospital products
Catheter systems
Cardiovascular systems
Vascular grafts
Cardiac & Vascular products
CAPD systems
Diabetes care products
Other productsHome health care products
Total(Millions of yen)
Year ended
March 31, 2006
Amount%18,21131.0%

18,09428.1%

77,155

31.2%

9,022

15.4%

8,733

13.6%

35,814

14.5%

4,103

7.0%

4,340

6.8%

16,913

6.9%

31,33753.4%

31,16848.5%

129,883

52.6%

11,64319.8%

14,95423.3%

49,226

19.9%

7,293

12.4%

8,933

13.9%

32,279

13.1%

1,610

2.8%

2,394

3.7%

7,424

3.0%

20,54835.0%

26,28240.9%

88,930

36.0%

1,954

3.3%

1,808

2.8%

7,738

3.1%

2,341

4.0%

2,852

4.4%

10,026

4.1%

2,540

4.3%

2,208

3.4%

10,4694.2%

6,836 11.6%
58,721 100.0%

6,868 10.6%
64,319 100.0%

28,23411.4%
247,048 100.0%

Note 1) Main Products belonging to each product segment
Product segment

Main Products

Disposable medical equipment

Syringes, Needles, Solution Administration sets, I.V.catheters,
Blood collection tubes, Electronic medical devices, etc.
I.V.solution, Prefilled syringes, Nutritional products, etc.
Blood bags, Blood transfusion administration sets, medical
electronic devices for blood collection, etc.
PTCA dilation catheters, Coronary stents, Guide wires,
Angiographic catheters, Cerebral aneurysm coils, etc.
Roller pumps, Hollow fiber oxygenators, Blood circuits, etc.
Artificial vascular grafts
Dialysis solution, etc.
Blood glucose monitors, etc.
Home oxygen systems, Home nutritional products, Digital
Thermometers, Electronic sphygmomanometers, etc.

Pharmaceuticals
Blood transfusion systems
Catheter systemsCardiovascular systems
Vascular grafts
CAPD systems
Diabetes care products
Other products(2) Sales results by region
Three months ended Three months ended
June 30, 2005
June 30, 2006
Amount%Amount%JapanEurope
America
Asia and Others
Total(Millions of yen)
Year ended
March 31, 2006
Amount%35,76960.9%35,40555.1%

149,386

60.5%

9,373

16.0%

11,47817.8%

39,587

16.0%

8,681

14.8%

11,77718.3%

38,617

15.6%

4,896
8.3%
58,721 100.0%

5,657
8.8%
64,319 100.0%

19,4577.9%
247,048 100.0%